The effects of gold nanoparticles (GNPs) in 125I brachytherapy dose enhancement on
choroidal melanoma are examined using the Monte Carlo simulation technique. Usually …

Purpose: For decades, 106Ru/106Rh ophthalmic applicators have been widely used to treat
intraocular malignancies with good clinical outcomes. Determining the dosimetry of such …

The present work proposes a new mathematical eye model for ophthalmic brachytherapy
dosimetry. This new model includes detailed description of internal structures that were not …

Background Episcleral brachytherapy is the most common eye-preserving option for treating
uveal melanoma, with ruthenium-106 widely used in Europe. Case series have reported on …

Background: The distribution of the emitter substance in 106 Ru eye plaques is usually
assumed to be homogeneous for treatment planning purposes. However, this distribution is …

106Ru eye plaques have been used to treat intraocular malignancies for over four decades
[5, 22, 23, 24, 25, 30]. Nevertheless, the determination of the dose distribution produced by …

Abstract Background/Aims: Ruthenium plaques are used for the treatment of ocular tumors.
There is, however, a controversy regarding the maximum treatable tumor height. Some …

For a few years at the Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele” of
Catania (Italy), ocular melanoma brachytherapic treatments with Ru-106 plaques have been …

Abstract The Low Energy Particle Track Simulation code is a radiation interaction simulation
tool specifically designed to describe electron and positron interactions below 10 keV at a …

Previous studies show remarkable differences in the simulation of electron depth dose
profiles of ruthenium eye plaques. We examined the influence of the scoring and simulation …